Episode
Rewriting the Playbook: Cellular Therapy and Vaccines for ALK-Positive Lung Cancer
- Podcast
- Lung Cancer Considered
- Published
- Jul 21, 2026
- Duration seconds
- 2859
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/lung-cancer-considered-246259/episodes/rewriting-the-playbook-cellular-therapy-and-vaccines-for-alk-positive-lung-cancer/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/lung-cancer-considered-246259/rewriting-the-playbook-cellular-therapy-and-vaccines-for-alk-positive-lung-cancer.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
How could cellular therapies and cancer vaccines transform the future of treatment for ALK-positive lung cancer? Host Dr. Narjust Florez sits down with Dr. Vincent Lam and Dr. Carmen Mecca to explore the latest research, the science driving these innovative approaches, and what these advances could mean for patients and the future of precision oncology. Key Topics Covered: • ALK-positive lung cancer • Cellular Therapy • Vaccines Guests: Vincent Lam, MD Associate Professor of Oncology, Johns Hopkins University School of Medicine Director, Thoracic Oncology Clinical Research Program Sidney Kimmel Comprehensive Cancer Center Carmen Mecca. PhD Postdoctoral Fellow, Chiarle Lab Department of Pathology Boston Children’s Hospital